Oblique Therapeutics AB (publ)
Innovative biotech developing breakthrough antibodies using the AbiProt platform.
Overview
- 10–19
- Employees
- 400–499K SEK
- Revenue
- 2015
- Founded
Description
Oblique Therapeutics is an innovative biotechnology company focused on transforming antibody therapeutics. They specialize in developing new antibody medicines, with a primary focus on severe diseases like pain that have large unmet clinical needs. The core of their operation is the pioneering AbiPr...